The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...

Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Super Bowl ads aren’t just entertainment; they’re cultural barometers. They reflect what resonates with audiences, what ...

The growth of the cell culture media market is driven by rising demand for biopharmaceuticals, vaccines, and cell-based therapies, fueled by advancem ...

President Trump, soon after unveiling new levies on steel and aluminum, said he will be "looking at" potential tariffs on the ...

Defence Minister Rajnath Singh is set to inaugurate the Global Investors Meet (GIM) – Invest Karnataka 2025 on February 11 at ...

Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.

"The handicapped and the elderly can be put at ease, and better images obtained with the use of this chair. I would highly ...

Not all advertising executives share his sangfroid. Today, technology is changing the industry faster than at any time since ...

The impact of dismantling USAID can be hard to grasp for anyone not intimately involved in this wonky corner of government. But Americans must pay attention to the incredible harm shutting down the ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...